Cargando…
School-Age Outcomes of Antenatal Magnesium Sulphate in Preterm Infants
Background: Antenatal magnesium sulphate (MgSO(4)) therapy given to women at risk of preterm birth reduced the risk of cerebral palsy in early childhood. However, its effect on longer-term neurological outcomes remains uncertain. This study aimed to assess the effects of antenatal MgSO(4) therapy on...
Autores principales: | Kobayashi, Akira, Ito, Masato, Ota, Erika, Namba, Fumihiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453514/ https://www.ncbi.nlm.nih.gov/pubmed/37628323 http://dx.doi.org/10.3390/children10081324 |
Ejemplares similares
-
Does Antenatal Administration of Magnesium Sulphate Prevent Cerebral Palsy and Mortality in Preterm Infants? A Study Protocol
por: Wolf, Hanne Trap, et al.
Publicado: (2015) -
Maternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: a systematic review
por: Bain, Emily S, et al.
Publicado: (2013) -
Clinical pharmacokinetic properties of magnesium sulphate in women with pre‐eclampsia and eclampsia
por: Okusanya, BO, et al.
Publicado: (2015) -
Antenatal magnesium sulphate and adverse neonatal outcomes: A
systematic review and meta-analysis
por: Shepherd, Emily, et al.
Publicado: (2019) -
Implementation of an antenatal magnesium sulfate protocol for fetal neuroprotection in preterm infants
por: Bouet, Pierre-Emmanuel, et al.
Publicado: (2015)